300POutcome of triple negative inflammatory breast cancers (TNIBC) treated with dose dense neoadjuvant epirubicin cyclophosphmide, prognostic impact of pre and post neoadjuvant che... von Campedel, L, Blanc-Durand, P, Binasker, A, Bécourt, S, Ledoux, F, Cuvier, C, Gardair, C, Teixeira, L, De Roquancourt, A, Lehmann Che, J, Espié, M, Giacchetti, S

Volltext

Outcome of triple negative inflammatory breast cancers (TNIBC) treated with dose dense neoadjuvant epirubicin cyclophosphmide, prognostic impact of pre and post neoadjuvant chemoth... von Campedel, L., Blanc-Durand, P., Binasker, A., Bécourt, S., Ledoux, F., Cuvier, C., Gardair, C., Teixeira, L., De Roquancourt, A., Lehmann Che, J., Espié, M., Giacchetti, S.

Volltext

300P - Outcome of triple negative inflammatory breast cancers (TNIBC) treated with dose dense neoadjuvant epirubicin cyclophosphmide, prognostic impact of pre and post neoadjuvant... von Campedel, L., Blanc-Durand, P., Binasker, A., Bécourt, S., Ledoux, F., Cuvier, C., Gardair, C., Teixeira, L., De Roquancourt, A., Lehmann Che, J., Espié, M., Giacchetti, S.

Volltext

Abstract P5-17-05: Outcome of triple negative inflammatory breast cancer (TNIBC) treated with dose-dense dose intense neoadjuvant chemotherapy (NAC), prognostic impact of post NAC... von Campedel, L, Binasker, A, Blanc-Durand, P, Becourt, S, Ledoux, F, Cuvier, C, Gardnair, C, Teixeira, L, de Roquancourt, A, Espie, M, Giacchetti, S

Volltext